ArticleCureus2025
Rapid Bone Metastasis in Hepatocellular Carcinoma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of risk factors for the development and prognosis of bone metastases in renal cell carcinoma: development and validation of a predictive model.American journal of cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular carcinoma (HCC) is the common malignancy of the liver. It frequently arises in patients with chronic hepatitis infections, with extrahepatic metastases, particularly to bone, typically occurring several months after initial diagnosis. We present a rare case of a 71-year-old female with a 22-year history of hepatitis C infection, and a three-year history of liver cirrhosis. During routine evaluation, a liver ultrasound revealed ill-defined lesions in both liver lobes. Subsequent contrast-enhanced computed tomography (CT) of the liver confirmed the diagnosis of hepatocellular carcinoma. The patient was referred to the oncology department for further management. Remarkably, within three weeks, the patient developed diffuse bone pain, prompting additional investigation. A bone scan revealed widespread skeletal metastases, indicating a rare, rapid progression of HCC. She was initiated on high-dose analgesics and received symptomatic care for other associated symptoms, which provided partial relief. This case highlights the potential for aggressive tumor behavior and the importance of early recognition of atypical metastatic presentations. This also underscores the need for more clinical awareness and prompt diagnostic imaging in similar presentations. Clinicians should maintain a high index of suspicion for bone metastasis in newly diagnosed HCC patients presenting with new-onset bone pain, even in early stages of diagnosis. Early detection and timely palliative intervention are crucial for improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.